MRC Biosafety Cabinet Evaluation
Closed Solicitation Posted
- Solicitation number
- 75F40125Q00050
- Agency
- FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541330 Engineering Services
- Place of performance
- Laurel, Maryland 20708, United States
- Points of contact
-
- Sheneil Green sheneil.green@fda.hhs.gov (301) 796-0675
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services Food and Drug Administration (FDA) is seeking engineering evaluation services for biological safety cabinets (BSCs) at the Muirkirk Research Complex in Laurel, Maryland. The solicitation requires a comprehensive assessment of six existing BSCs that are not meeting certification or require replacement due to age, with a focus on associated HVAC and control systems. Contractors must attend a mandatory site visit on December 17, 2024, and submit questions by December 19, 2024, with final quotes due by January 8, 2025. The evaluation will be based primarily on technical approach and prior relevant experience, with technical factors considered significantly more important than price. Quoters must provide a technical response limited to 5 pages, including a projected completion date and detailed examination of the BSCs' current performance and potential replacement specifications.
The contract is a 100% small business set-aside under NAICS code 541330 with a $25.5M size standard, targeting engineering services firms. The anticipated award is a firm-fixed price purchase order with a 100-day period of performance, expected to run from January to April 2025. Deliverables include a pre-final report due within 60 days of award and a final report due within 90 days, both requiring comprehensive findings and recommendations. Contractors will be responsible for conducting detailed airflow measurements, reviewing building automation systems, and providing rough order of magnitude cost estimates for BSC replacements. The total project scope involves examining six biological safety cabinets at the FDA's Muirkirk Research Complex, with work to be performed entirely in Laurel, Maryland. The government will evaluate quotes based on technical approach, prior relevant experience, and price, with technical factors being the primary consideration.
Notice text
2 versions
Update #2 · Latest ·
AMENDMENT 01
FDA issues the subject Amendment 01 incorporating all questions and answers submitted in response to the RFQ, and extending the quote deadline. Please review in its entirety.
Quotation Deadline: The deadline for receipt of quotations in response to this requirement is extended to Wednesday, January 8, 2025, at 12:00pm ET. Quote submissions are to be submitted to the CO using subject line “75F40125Q00050 – CVM Evaluation of Biological Safety Cabinets”. Quoters shall not submit electronic documents using Microsoft Office Suite products that contain the use of “macros”.
---------------------------------------------------------------------------------------------------------------------------------------------
ORIGINAL SOLICITATION
SEE ATTACHED SOLICITATION
IMPORTANT DATES AND INFORMATION
I. Mandatory Site Visit: All Quoters must attend at no cost to the Government, a Site Survey:
When: Tuesday, December 17, 2024, from 10:00am to 12:00pm ET.
Where: US Food and Drug Administration, Muirkirk Research Complex in Laurel, Maryland.
Firms are to arrive no later than 9:30am ET. The Quoter must electronically provide to the Contracting Officer (CO), Sheneil Green at Sheneil.Green@fda.hhs.gov no later than 9:00am, December 16, 2024,the below information. All attendees must have a valid Government issued ID:
- Full name and telephone number of individual attendees
- Company Name, address, and telephone number.
The CO will provide the specific site visit location and point of contact information via confirmation email.
II. Question Deadline: Thursday, December 19, 2024, at 12:00pm ET. Questions related to this procurement shall be submitted via email to CO at sheneil.green@fda.hhs.gov. No phone calls will be accepted. Questions received after the deadline will not be considered. Responses will be posted to SAM.gov.
III. Quotation Deadline: The deadline for receipt of quotations in response to this requirement is Tuesday, December 24, 2024, at 12:00pm ET. Quote submissions are to be submitted to the CO using subject line “75F40125Q00050 – CVM Evaluation of Biological Safety Cabinets”. Quoters shall not submit electronic documents using Microsoft Office Suite products that contain the use of “macros”.
Update #1 ·
SEE ATTACHED SOLICITATION
IMPORTANT DATES AND INFORMATION
I. Mandatory Site Visit: All Quoters must attend at no cost to the Government, a Site Survey:
When: Tuesday, December 17, 2024, from 10:00am to 12:00pm ET.
Where: US Food and Drug Administration, Muirkirk Research Complex in Laurel, Maryland.
Firms are to arrive no later than 9:30am ET. The Quoter must electronically provide to the Contracting Officer (CO), Sheneil Green at Sheneil.Green@fda.hhs.gov no later than 9:00am, December 16, 2024,the below information. All attendees must have a valid Government issued ID:
- Full name and telephone number of individual attendees
- Company Name, address, and telephone number.
The CO will provide the specific site visit location and point of contact information via confirmation email.
II. Question Deadline: Thursday, December 19, 2024, at 12:00pm ET. Questions related to this procurement shall be submitted via email to CO at sheneil.green@fda.hhs.gov. No phone calls will be accepted. Questions received after the deadline will not be considered. Responses will be posted to SAM.gov.
III. Quotation Deadline: The deadline for receipt of quotations in response to this requirement is Tuesday, December 24, 2024, at 12:00pm ET. Quote submissions are to be submitted to the CO using subject line “75F40125Q00050 – CVM Evaluation of Biological Safety Cabinets”. Quoters shall not submit electronic documents using Microsoft Office Suite products that contain the use of “macros”.
Attachments
| File | Type | Posted |
|---|---|---|
| SF30_75F40125Q00050_Amend 01.pdf | ||
| 75F40125Q00050_Amend 01_QA.pdf | ||
| RFQ_75F40125Q00050_SAM_Amend 01.pdf | ||
| Attach A_Price Schedule_75F40125Q00050.xlsx | XLSX spreadsheet | |
| SF1449_75F40125Q00050.pdf | ||
| SAM_RFQ_75F40125Q00050.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity